🇺🇸 FDA
Patent

US 6083502

Mesothelium antigen and methods and kits for targeting it

expired A61KA61K2039/505A61K2123/00

Quick answer

US patent 6083502 (Mesothelium antigen and methods and kits for targeting it) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jul 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K2039/505, A61K2123/00, A61K47/6851, A61K47/6869